Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-B15832-50 50 µl (1 mg/ml) $460 
CD39 Antibody - Human Spleen: Formalin-Fixed, Paraffin-Embedded (FFPE)
CD39 Antibody - Human Placenta: Formalin-Fixed, Paraffin-Embedded (FFPE)
CD39 Antibody
CD39 Antibody - Human Spleen: Formalin-Fixed, Paraffin-Embedded (FFPE)
CD39 Antibody - Human Placenta: Formalin-Fixed, Paraffin-Embedded (FFPE)
CD39 Antibody
1 of 3
2 of 3
3 of 3

IHC‑plus™ Polyclonal Rabbit anti‑Human CD39 Antibody (IHC, WB) LS‑B15832

IHC‑plus™ Polyclonal Rabbit anti‑Human CD39 Antibody (IHC, WB) LS‑B15832

Note: This antibody replaces LS-C668091
Antibody:
CD39 Rabbit anti-Human Polyclonal Antibody
Application:
IHC-P, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Price
Catalog Number
$460
LS-B15832-50
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
CD39 Rabbit anti-Human Polyclonal Antibody
Application:
IHC-P, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified

Specifications

Description
CD39 antibody LS-B15832 is an unconjugated rabbit polyclonal antibody to CD39 from human. It is reactive with human, mouse and rat. Validated for IHC and WB. Tested on 20 paraffin-embedded human tissues.
Target
Human CD39
Synonyms
ENTPD1 | ATPDase | CD39 | CD39 antigen | Ecto-apyrase | Ecto-ATPDase 1 | Ecto-ATP diphosphohydrolase 1 | Ecto-ATPase 1 | NTPDase-1 | NTPDase 1
Host
Rabbit
Reactivity
Human, Mouse, Rat (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity chromatography
Modifications
Unmodified
Immunogen
KLH-conjugated synthetic peptide of human CD39
Specificity
Recognizes endogenous levels of CD39 protein.
Applications
  • IHC - Paraffin (1:100)
  • Western blot (1:500 - 1:2000)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
Western blot analysis of CD39 expression in A549 (A), MCF7 (B), mouse lung (C), rat kidney (D) whole cell lysates.
Presentation
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Storage
Aliquot and store at -20°C for 1 year. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CD39
P49961 NM_001776 NP_001767.3

Validation

CD39 Antibody - Human Spleen: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Spleen: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Spleen: Formalin-Fixed, Paraffin-Embedded (FFPE)

CD39 Antibody - Human Placenta: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Placenta: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Placenta: Formalin-Fixed, Paraffin-Embedded (FFPE)

LSBio Ratings

IHC-plus™ CD39 Antibody for IHC, WB/Western LS-B15832 has an LSBio Rating of
Laboratory Validation Score (4)

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/23/2024